NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow DownZacks Investment Research • 01/15/25
Eli Lilly and Company (LLY) CEO Dave Ricks presents at 43rd Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/15/25
S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook WeakensInvestopedia • 01/14/25
Eli Lilly lowers FY revenue forecast as weight loss drug sales fall shortProactive Investors • 01/14/25
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on TuesdayThe Motley Fool • 01/14/25
Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales SlowInvestors Business Daily • 01/14/25